Arbutus Biopharma
Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

$604.5M

Market Cap • 12/26/2024

2005

(19 years)
Founded

2007

(17 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Warminster

Headquarters • Pennsylvania